The cell cycle: Regulation and anomalies in epidermal tumours;Le cycle cellulaire: Sa regulation et ses anomalies dans les tumeurs epidermiques

Annales de Dermatologie et de Venereologie

Volumn 124, Issue 6-7, 1997, Pages 452-456

  Heenen, M ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; CELL CYCLE; CELL DEATH; HUMAN; MELANOMA; REGULATORY MECHANISM; SKIN TUMOR; SPINDLE CELL CARCINOMA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

CYCLIN DEPENDENT KINASE; PROTEIN P16INK4A; PROTEIN P53;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL DEATH; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MUTATION; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031317650     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Laporte M., Heenen M. The heterogeneity of the germinative compartment in human epidermis and its implications in psoriasis. Dermatology. l994;189:340-3.
2. Iversen O.H., Elgjo K., Reichelt K.L. Purification and characterization of a mitosis inhibiting epidermal pentapeptide. Cell. Biol. Int. Rep. 1984;8:379-83.
3. Pines J. Cyclins and cyclin-dependant kinases: theme and variations. Advances in Cancer Res. 1995;66:181-212.
4. Majno G., Joris I. Apoptosis, oncosis and necrosis. Am. J. Pathol. 1995;146:3-15.
5. Kranenburg O., Van der Eb A.J., Zantema A. Cyclin-dependant kinases and pRb: regulators of the proliferation-differentiation switch. FEBS Letters 1995;367:103-6.
6. Pater M., Herskowitz I. Joining the complex: cyclin-dependant kinase inhibitory proteins and the cell cycle. Cell. 1994;79:181-4.
7. Hannon G.J., Beach D. p15 is a potential effector of TGFβ-induced cell cycle arrest, Nature l994;371:257-61.
8. Jackson P.K., Chevalier S., Philippe M., Kirschner M.W. Early events in DNA replication require cyclin E and are blocked by p20 ? J. Cell. Biol. 1995;130:755-69.
9. Vogelstein B., Kinzler K.W. p53 function and dysfunction. Cell. 1992;70:523-6.
10. Selivanova G., Wiman K.G. p53: a cell cycle regulator activated by DNA damage. Advances in Cancer Res. 1995;66:143-80.
11. Barak Y., Oren M. Enhanced binding of a 95 kd protein in cells undergoing p53-mediated growth arrest. EMBO J. 1992;11:2115-21.
12. Zhang H., Kobayashi R., Galaktionov K., Beach D. p19 and p45 are essential elements of the cyclin A-cdk2 S-phase kinase. Cell. 1995;82:915-25.
13. Guadagno T.M., Newport J.W. Cdk2 kinase is required for entry into mitosis as a positive regulator of cdc2-cyclin B kinase activity. Cell. 1996;84:73-82.
14. Waldman T., Lengauer C., Kinzler K.W., Vogelstein B. Uncoupling of S-phase and mitosis enduced by anticancer agents in cells lacking p2l. Nature l996;381:713-6.
15. Williams G.T., Smith C.A. Molecular regulation of apoptosis: genetic control on cell death. Cell. 1993;74:777-9.
16. Chao D.T., Linette G.P., Boise L.H., White L.S., Thompson C.B., Korsmeyer S. Bcl xl and Bcl2 repress a common pathway of cell death. J. Exp. Med. 1995;182:821-8.
17. Evan G.I., Wyllie A. H., Gilben C.S. Induction of apoptosis in tibroblast by c-myc protein. Cell. 1992;69:119-20.
18. Schwartz S.M., Bennett M.R. Death by any other name. Am. J. Pathol. 1995;147:229-34.
19. Demetrich D.J., Matsumoto S., Hannon G.J., Okamoto K., Xiong Y., Zhang H., Beach D.H. Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC). cyclin E (CCNE), p21 (CDKN1) and kap (CDKN3). Cytogenic Cell. Genet. 1995;69:190-2.
20. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Pathol. 1995;147:545-60.
21. Hunter J., Pines J. Cyclins and Cancer II: cyclin D and cdk inhibitors come of age. Cell. 1994;79:573-82.
22. Hirama T., Koeffler. Role of the cyclin-dependant kinase inibitors in the development of cancer. Blood 1995;86:841-54.
23. Lee M.J., Bernstein A. Apoptosis, cancer and the p53 tumour suppressor gene. Cancer and Metastasis Reviews 1995;14:149-61.
24. Urano Y., Asano T., Yoshimoto K., Iwakana H., Kubo Y., Kato S., Sasaki S., Takeuchi N., Uchida N., Nakanishi H., Arase S., Itakura M. Frequent p53 accumulation in the chronically sun-exposed epidermis and clonal expansion of p53 mutant cells in the epidermis adjacent to basal cell carcinoma. J. Invest. Dermatol. 1995;104:928-32.
25. Nakagawa K., Yamamura K., Maeda S., Ichihashi M. Bcl2 expression in epidermal keratinocytic diseases. Cancer 1994;1720-4.
26. Verhaegh M.E.J.M., Sanders C.J.G., Arends J.W., Newmann H.A.M. Expression of the apoptosis-suppressing protein in Bcl2 in non-melanoma skin cancer. Br. J. Dermatol. 1995;132:740-4.
27. Morales Ducret C.R.J., Van de Rijn M., Lebrun D.P., Smoller B.R. Bcl2 expression in primary malignancies of the skin. Arch. Dermatol. 1995;131;909-12.
28. Crowson A.N., Magro C.M., Kadin M.E., Stranc M. Differential expression of the Bcl2 oncogene in human basal cell carcnoma. Human Pathol. 1996;27:355-9.
29. Zhang S., Klein szanto A., Sauter E.R., Shafarenko M., Milsuanaga S., Nobori T., Carson D.A., Ridge J.A., Goodrow T.L. Higher frequency of alterations in the p16/cdkn2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res. 1994;54:5050-3.
30. Inohara S., Kitano Y. Immunohistochemical detection of cyclin D and cyclin A in human hyperproliferative epidermis. Arch. Dermatol. Res. l994;286:504-6.
31. Bartkova J., Lukas J., Muller H., Strauss M., Gusterson B., Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 1995;55:949-56.
32. Brash D.E., Rudolph J.A., Simon J.A. A role of sunlight in skin cancer: UV-induces p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA l99l;88:10124-8.
33. Ziegler A., Jonason A.S., Lefell D.J., Simon A.J., Sharma H.W., Kimmelman J., Remington L., Jacks T. Sunburn and p53 in the onset of skin cancer. Nature 1994;372:773-6.
34. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., Carson D.A. Deletions of the cyclin-dependant kinase-4 inhibitors gene in multiple human cancers. Nature l994;368:753-6.
35. Walker G.J., Palmer J.M., Walters M.K. and Hayward N.K.A. A genetic model of melanoma tumorogenesis based on allelic losses. Genes Chromosomes Cancer 1995;12:134-41.
36. Stretch J.R., Gatter K.G., Ralfkiar E., Lane D.P., Harris A.L. Expression of mutant p53 in melanoma. Cancer Res. 1991:51:5976-9.
37. Weiss J., Heine M., Korner B., Pilch H., Jung E.G. Expression of p53 protein in malignant melanoma: clinico-pathological and prognostic implications. Br. J. Dermatol. l995:133:23-31.
38. Wang Y.L., Uhara H., Yamazaki Y., Mikaido T., Saida T. Immunohistochemical detection of cdk4 and pl6 proteins in cutaneous malignant melanoma. Br. J. Dermatol. 1996;13:269-75.
39. Heenen M., Achten G., Galand P. Autoradiographic analysis of cell kinetics in human normal epidermis and basal cell carcinoma. Cancer Res. 1973;33:123-7.
40. Heenen M., Galand P. Decreased rate of DNA chain growth in human basal cell carcinoma. Nature 1980;285:265-7.
41. Galand P., Heenen M. DNA replication fork progression rate and temporal organization of S-phase in normal human epidermis and in basal cell carcinoma. J. Cell. Physiol. 1988;137:374-7.
42. Bresciani F., Paoluzzi R., Benassi M., Nervi C., Casale C., Ziparo E. Cell kinetics and growth of squamous cell carcinoma in man. Cancer Res. 1974;34:2405-15.